SABS (SAB Biotherapeutics) Short-Term Debt to Capital
SAB Biotherapeutics (SABS) is implementing a breakthrough antibody production method via transchromosomal cattle, ensuring sterility and supply volumes for oncology treatment. This daily price chart reflects a current value of 0.00. Highly qualified top executives are targeting therapies for infectious pathologies. However, SAB Biotherapeutics (SABS) faces a cash shortage, as the maintenance of research centers is leading to a gradual depletion of existing reserves.
Analytical breakdowns for SAB Biotherapeutics
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital SAB Biotherapeutics|SABS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio SAB Biotherapeutics, Inc.|SABS - Aggregate Debt Obligations|Debts to Book Capitalization SAB Biotherapeutics Inc.|SABS - Long-Term Debt Volume|Company Short-Term Debt SAB Biotherapeutics|Quick Liquidity sabbiotherapeutics.com
- company profitability and valuation multiples indicators:
Fundamental valuation:SAB Biotherapeutics, Inc
For SAB Biotherapeutics (SABS), which lacks regular income due to its focus on antibody development, liquidity management is critical. This metric compares liabilities maturing within one year against equity, allowing investors to assess default risk or excessive management conservatism through the dynamics of short-term liabilities relative to equity to determine the company's financial stability.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KALV - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Septerna Pharma SEPN|PVLA: Short-Term Debt to Capital|savarapharma.com (SVRA) - Short-Term Debt to Capital|RIGL (Rigel Pharmaceuticals, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity ANAB|Short-Term Debt to Equity Ratio ATXS (Astria Pharma)|ENGN (enGene Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital RAPT (RAPT Therapeutics)|Aerovate Therapeutics, Inc. - Short-Term Debt to Equity|Aclaris Therapeutics, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences PLC (TLSA) - Short-Term Debt to Equity|Current Liabilities to Capital Cabaletta Bio Inc (CABA)|Short-Term Debt to Equity Ratio VTYX|THTX (theratech.com) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital AVTX|ELDN (Eledon Pharmaceuticals Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AGEN (Agenus Inc)|Climb Bio, Inc (CLYM) - Current Liabilities to Capital|ZURA - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital ATYR (atyrpharma.com)|ADAG: Short-Term Debt to Capital|Ikena Oncology (IMA) - Short-Term Debt to Capital|Short-Term Debt to Equity Shattuck Labs Inc|Equillium Bio - Current Liabilities to Equity|Short-Term Debt to Capital CNTB|IMUX - Current Liabilities to Capital|Atara Bio - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital InflaRx NV IFRX|XFOR: Short-Term Debt to Equity Ratio|Adicet Bio - Short-Term Loans to Capital Ratio|CELU: Short-Term Debt to Capital|INMB - Short-Term Debt to Capital Coefficient|BRNS (Barinthus Biotherapeutics plc) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Kezar Life Sciences Inc. (KZR)|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|Short-Term Debt to Capital Coefficient enlivex.com|Short-Term Debt to Equity Q32 Bio QTTB|Short-Term Debt to Capital Coefficient geovax.com (GOVX)|Edesa Biotech - Short-Term Debt to Capital|IBIO - Short-Term Debt to Capital|CARM: Short-Term Debt to Capital|XTLB (XTL Bio) - Short-Term Debt to Equity|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCW Biologics Inc (HCWB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|AIM: Current Liabilities to Equity|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Ratio of Short-Term Indebtedness to Capital GRI|XORTX Therapeutics Inc. - Short-Term Debt to Capital|HIND - Short-Term Debt to Capital|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Indaptus Therapeutics Inc - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Scinai|Short-Term Debt to Equity Ratio CalciMedica Corp (CALI)|Short-Term Debt to Capital AFMD|Short-Term Debt to Capital allakos.com (ALLK)|HOOKIPA Pharma - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital IGMS|iTeos - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Ocean Biomedical Corp OCEA|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio thirdharmonicbio.com